Brooks Laboratories Limited, incorporated in 2002, is a pharmaceutical manufacturing company specializing in contract manufacturing of injectables, tablets, and dry syrups for domestic clients. The company operates two cGMP-compliant facilities in Baddi, Himachal Pradesh, and Vadodara, Gujarat, with the latter being EU certified. Brooks Laboratories serves the critical care segment with a diverse product portfolio, including Beta Lactam, Cephalosporin injectables, and tablets, and collaborates with major pharmaceutical companies such as Zydus Cadila and Wockhardt Ltd.
The company has established a strong presence in pharmaceutical formulation development, production, and exports, both in India and internationally. Over the years, Brooks Laboratories has expanded its facilities, with significant upgrades and expansions, including a world-class carbapenem facility in Vadodara. The Baddi plant has operated at high capacity, and recent upgrades have doubled its production capacity. The company's commitment to quality and compliance is evidenced by certifications from ISO and WHO GMP.
